Technical Analysis for ABVC - American Brivision (Holding) Corp

Grade Last Price % Change Price Change
grade F 2.8 1.82% 0.0500
ABVC closed up 1.82 percent on Monday, February 24, 2020, on 1.69 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong N/A Down Flat
Historical ABVC trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Hammer Candlestick Bullish 1.82%
Bollinger Band Squeeze Range Contraction 1.82%
BB Squeeze Started Range Contraction 1.82%
20 DMA Resistance Bearish 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Older signals for ABVC ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company's licensed products include ABV-1501, a combination therapy for triple negative breast cancer; ABV-1502, a combination therapy for solid tumors with Anti-PD1; ABV-1503, a combination therapy for chronic lymphocytic leukemia; ABV-1504 for depressive disorders; ABV-1505, a combination therapy for attention deficit hyperactivity disorder; BFC-1401, a vitreous substitute for vitrectomy; and Maitake combination therapy. It has a co-development agreement with Rgene Corporation to develop Maitake combination therapy products, such as ABV-1507 HER2/neu positive breast cancer combination therapy, ABV-1511 pancreatic cancer combination therapy, and ABV-1527 ovary cancer combination therapy; and collaborative agreements with BioLite Inc and BioFirst Corporation. The company was founded in 2015 and is based in Goshen, New York. American BriVision (Holding) Corporation is a subsidiary of YuanGene Corporation.
Health RTT Cancer Biopharmaceutical Solid Tumors Drug Discovery Breast Cancer Cancer Treatments Therapy Stage Biopharmaceutical Pancreatic Cancer Medicinal Chemistry Triple Negative Breast Cancer Attention Deficit Hyperactivity Disorder Chronic Lymphocytic Leukemia Her2/Neu Depressive Disorders Grifola Frondosa

Is ABVC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.0
52 Week Low 1.25
Average Volume 2,075
200-Day Moving Average 0.0000
50-Day Moving Average 4.1793
20-Day Moving Average 2.8380
10-Day Moving Average 2.8030
Average True Range 0.2543
ADX 58.33
+DI 11.1083
-DI 35.4291
Chandelier Exit (Long, 3 ATRs ) 2.7471
Chandelier Exit (Short, 3 ATRs ) 3.0129
Upper Bollinger Band 3.1432
Lower Bollinger Band 2.5328
Percent B (%b) 0.44
BandWidth 21.5081
MACD Line -0.3775
MACD Signal Line -0.4669
MACD Histogram 0.0895
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.9500
Resistance 3 (R3) 2.9667 2.9333 2.9250
Resistance 2 (R2) 2.9333 2.8951 2.9250 2.9167
Resistance 1 (R1) 2.8667 2.8715 2.8500 2.8500 2.9083
Pivot Point 2.8333 2.8333 2.8250 2.8250 2.8333
Support 1 (S1) 2.7667 2.7951 2.7500 2.7500 2.6917
Support 2 (S2) 2.7333 2.7715 2.7250 2.6833
Support 3 (S3) 2.6667 2.7333 2.6750
Support 4 (S4) 2.6500